“XP-23829, a Novel Fumaric Acid Ester, Is Efficacious in Reducing Psoriatic Lesions: Results from a Phase 2 Randomized Controlled Study”. SKIN The Journal of Cutaneous Medicine, vol. 1, no. 3.1, Oct. 2017, p. s33, https://doi.org/10.25251/skin.1.supp.32.